Evidence map›Paper›PMID 40634826›Full record

ArticleAIDS and behavior2025

Changes in the PrEP Care Cascade in People Who Inject Drugs in 2018 and 2022.

Hunter C Spencer, Matthew A Town, LaLaine Sevillano, Lauren Lipira, Tim W Menza

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in AIDS and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hunter C SpencerDepartment of General Internal Medicine, Oregon Health and Sciences University, 3181 SW Sam Jackson Park Rd., PortlandPortland, OR, 97239, USA. spencerh@ohsu.edu.ORCID http://orcid.org/0000-0002-5710-1836
Matthew A TownChime In, HIV STI and TB Section, Oregon Health Authority, Portland, OR, USA.ORCID http://orcid.org/0000-0001-9541-0624
LaLaine SevillanoChime In, HIV STI and TB Section, Oregon Health Authority, Portland, OR, USA.ORCID http://orcid.org/0000-0002-5522-6715
Lauren LipiraChime In, HIV STI and TB Section, Oregon Health Authority, Portland, OR, USA.ORCID http://orcid.org/0000-0002-8732-6403
Tim W MenzaChime In, HIV STI and TB Section, Oregon Health Authority, Portland, OR, USA.ORCID http://orcid.org/0000-0003-4154-7718

Funding

Oregon Clinical and Translational Research Institute KL2 SupplementKL2TR002370 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Catherine Lee Hough · 2017 to 2026
$10.1M
CDC HHS NU62PS924776NCATS NIH HHS KL2 TR002370NCATS NIH HHS KL2TR002370
6 · The paper itself

Abstract

HIV pre-exposure prophylaxis (PrEP) prevents HIV transmission. However, PrEP remains underutilized among people who inject drugs (PWID), even when clinically indicated. Here, we assess changes in PrEP awareness, access, and use in 2018 and 2022 and factors associated with PrEP awareness in 2022. We analyzed a sample of PWID not living with HIV with an indication for PrEP based on National HIV Behavioral Surveillance (NHBS) in Portland, Oregon during the 2018 and 2022 survey cycles. We compared PrEP awareness, access, and use in 2018 and 2022 with χ

Indexed as

Anti-HIV AgentsDrug UsersHealth Knowledge, Attitudes, PracticeHIV InfectionsPre-Exposure ProphylaxisSubstance Abuse, IntravenousAdultFemaleHealth Services AccessibilityHumansMaleMiddle AgedOregonSurveys and QuestionnairesYoung AdultAnti-HIV AgentsHIVHIV PreventionPeople who inject drugs (PWID)Pre-exposure prophylaxis (PrEP)PrEP awareness

Identifiers

PMID40634826
PMCPMC12676974

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.